331 related articles for article (PubMed ID: 31268966)
1. Official International Association for Therapeutic Drug Monitoring and Clinical Toxicology Guideline: Development and Validation of Dried Blood Spot-Based Methods for Therapeutic Drug Monitoring.
Capiau S; Veenhof H; Koster RA; Bergqvist Y; Boettcher M; Halmingh O; Keevil BG; Koch BCP; Linden R; Pistos C; Stolk LM; Touw DJ; Stove CP; Alffenaar JC
Ther Drug Monit; 2019 Aug; 41(4):409-430. PubMed ID: 31268966
[TBL] [Abstract][Full Text] [Related]
2. Clinical feasibility of dried blood spots: Analytics, validation, and applications.
Enderle Y; Foerster K; Burhenne J
J Pharm Biomed Anal; 2016 Oct; 130():231-243. PubMed ID: 27390013
[TBL] [Abstract][Full Text] [Related]
3. Manual punch versus automated flow-through sample desorption for dried blood spot LC-MS/MS analysis of voriconazole.
Martial LC; van den Hombergh E; Tump C; Halmingh O; Burger DM; van Maarseveen EM; Brüggemann RJ; Aarnoutse RE
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jul; 1089():16-23. PubMed ID: 29747155
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of an analytical method using UPLC-MS/MS to quantify everolimus in dried blood spots in the oncology setting.
Knapen LM; Beer Y; Brüggemann RJM; Stolk LM; Vries F; Tjan-Heijnen VCG; Erp NPV; Croes S
J Pharm Biomed Anal; 2018 Feb; 149():106-113. PubMed ID: 29112898
[TBL] [Abstract][Full Text] [Related]
5. Dried blood spot sampling for therapeutic drug monitoring: challenges and opportunities.
Müller IR; Linden G; Charão MF; Antunes MV; Linden R
Expert Rev Clin Pharmacol; 2023; 16(8):691-701. PubMed ID: 37300458
[TBL] [Abstract][Full Text] [Related]
6. Quality Assessment of Dried Blood Spots from Patients With Tuberculosis from 4 Countries.
Zuur MA; Veenhof H; Aleksa A; Vanʼt Boveneind-Vrubleuskaya N; Darmawan E; Hasnain MG; Heysell SK; Jongedijk EM; Koster RA; Magis-Escurra C; Martinez N; Molinas G; Mondal D; Mulyani UA; Perwitasari DA; Tsivunchyk A; Touw DJ; Alffenaar JC
Ther Drug Monit; 2019 Dec; 41(6):714-718. PubMed ID: 31169760
[TBL] [Abstract][Full Text] [Related]
7. Preanalytical considerations in therapeutic drug monitoring of immunosuppressants with dried blood spots.
Klak A; Pauwels S; Vermeersch P
Diagnosis (Berl); 2019 Mar; 6(1):57-68. PubMed ID: 30808156
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic drug monitoring by dried blood spot: progress to date and future directions.
Wilhelm AJ; den Burger JC; Swart EL
Clin Pharmacokinet; 2014 Nov; 53(11):961-73. PubMed ID: 25204403
[TBL] [Abstract][Full Text] [Related]
9. Dried blood spots analysis with mass spectrometry: Potentials and pitfalls in therapeutic drug monitoring.
Antunes MV; Charão MF; Linden R
Clin Biochem; 2016 Sep; 49(13-14):1035-46. PubMed ID: 27179588
[TBL] [Abstract][Full Text] [Related]
10. Dried blood spots: concepts, present status, and future perspectives in bioanalysis.
Sharma A; Jaiswal S; Shukla M; Lal J
Drug Test Anal; 2014 May; 6(5):399-414. PubMed ID: 24692095
[TBL] [Abstract][Full Text] [Related]
11. Dried Blood Spots-A Platform for Therapeutic Drug Monitoring (TDM) and Drug/Disease Response Monitoring (DRM).
Zailani NNB; Ho PC
Eur J Drug Metab Pharmacokinet; 2023 Sep; 48(5):467-494. PubMed ID: 37495930
[TBL] [Abstract][Full Text] [Related]
12. From "wet" matrices to "dry" blood spot sampling strategy: a versatile LC-MS/MS assay for simultaneous monitoring caffeine and its three primary metabolites in preterm infants.
Dai HR; Guo HL; Wang WJ; Shen X; Cheng R; Xu J; Hu YH; Ding XS; Chen F
Clin Chem Lab Med; 2024 Jan; 62(1):97-110. PubMed ID: 37435827
[TBL] [Abstract][Full Text] [Related]
13. Development and clinical applications of the dried blood spot method for therapeutic drug monitoring of anti-epileptic drugs.
Min KL; Ryu JY; Chang MJ
Basic Clin Pharmacol Toxicol; 2019 Sep; 125(3):215-236. PubMed ID: 31199557
[TBL] [Abstract][Full Text] [Related]
14. Dried Blood Spot Self-Sampling by Guardians of Children With Epilepsy Is Feasible: Comparison With Plasma for Multiple Antiepileptic Drugs.
Linder C; Neideman M; Wide K; von Euler M; Gustafsson LL; Pohanka A
Ther Drug Monit; 2019 Aug; 41(4):509-518. PubMed ID: 30807537
[TBL] [Abstract][Full Text] [Related]
15. Procedures and practices for the validation of bioanalytical methods using dried blood spots: a review.
Jager NG; Rosing H; Schellens JH; Beijnen JH
Bioanalysis; 2014 Sep; 6(18):2481-514. PubMed ID: 25384597
[TBL] [Abstract][Full Text] [Related]
16. Dried Blood Spot Analysis for Therapeutic Drug Monitoring of Antipsychotics: Drawbacks of Its Clinical Application.
Kloosterboer SM; de Winter BCM; Bahmany S; Al-Hassany L; Dekker A; Dieleman GC; van Gelder T; Dierckx B; Koch BCP
Ther Drug Monit; 2018 Jun; 40(3):344-350. PubMed ID: 29505492
[TBL] [Abstract][Full Text] [Related]
17. Evaluating an easy sampling method using dried blood spots to determine vedolizumab concentrations.
Bian S; Van den Berghe N; Vandersmissen L; Tops S; Vermeire S; Ferrante M; Gils A; Thomas D
J Pharm Biomed Anal; 2020 Jun; 185():113224. PubMed ID: 32151929
[TBL] [Abstract][Full Text] [Related]
18. Dried blood spots as a sampling technique for the quantitative determination of guanfacine in clinical studies.
Li Y; Henion J; Abbott R; Wang P
Bioanalysis; 2011 Nov; 3(22):2501-14. PubMed ID: 22122599
[TBL] [Abstract][Full Text] [Related]
19. Determination of oxycodone and its major metabolites in haematic and urinary matrices: Comparison of traditional and miniaturised sampling approaches.
Protti M; Catapano MC; Samolsky Dekel BG; Rudge J; Gerra G; Somaini L; Mandrioli R; Mercolini L
J Pharm Biomed Anal; 2018 Apr; 152():204-214. PubMed ID: 29414014
[TBL] [Abstract][Full Text] [Related]
20. Dried Blood Spot sampling in psychiatry: Perspectives for improving therapeutic drug monitoring.
Martial LC; Aarnoutse RE; Mulder M; Schellekens A; Brüggemann RJM; Burger DM; Schene AH; Batalla A
Eur Neuropsychopharmacol; 2017 Mar; 27(3):205-216. PubMed ID: 28130001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
